Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Prochazka Katharina |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Gaksch, L; Uhl, B; Pansy, K; Schukoff, T; Greinix, HT; Beham-Schmid, C; Neumeister, P; Prochazka, KT; Deutsch, AJ
Distinct chemokine receptor expression profles
are associated with the clinicopathological
features of follicular lymphoma
Frühjahrstagung 2022 der OeGHO; AP 8-10,2022; Graz. 2022.
[Poster]
FullText
Gaksch, L; Uhl, B; Pansy, K; Schukoff, T; Greinix, H; Beham-Schmid, C;
Neumeister, P; Prochazka, K; Deutsch, A
Verschiedene Expressionsprofile von Chemokinrezeptoren sind mit der
Pathogenese des follikulären Lymphoms assoziiert
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische 2021; OCT 1-4, 2021; Berlin. 2021.
[Poster]
FullText
Feichtinger, J; Fechter, K; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA
Cytoplasmic NR4A1 in Diffuse Large B Cell Lymphoma
5th International CCS Workshop and 15th International CLL Workshop Salzburg 2019; APR 5-6, 2019; Fuschl am See. 2019.
[Poster]
Feichtinger, J;
Fechter, K;
Prochazka, K;
Unterluggauer, JJ;
Pansy, K;
Steinbauer, E;
Pichler, M;
Haybaeck, J;
Prokesch, A;
Greinix, HT;
Beham-Schmid, C;
Neumeister, P;
Thallinger, GG;
Deutsch, AJA;
Cytoplasmic NR4A1 in aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019.
[Poster]
Bergmann, TC; Pursche, B; Greinix, H; Neumeister, P; Deutsch, A; Prochazka, K
Overexpression of miR199a and miR497 regulates Nf-kappa B and B-cell receptor signalling in diffuse large B-cell lymphoma (DLBCL)
ONCOL RES TREAT. 2018; 41: 81-82.
[Poster]
Web of Science
Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P
Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82.
[Poster]
Web of Science
Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83.
[Poster]
Web of Science
Fechter, K; Pansy, K; Wenzl, K; Prochazka, K;Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
Frühjahrstagung der Österreichischen Gesellschaff für Hämatologie und Medizinische Onkologie
; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Poster]
Pabst G, Prochazka K, Pregartner G, Rücker FG, Heitzer E, Woelfler A, Zebisch A, Berghold A, Döhner K and Sill H.
Impact of TP53 mutated subclones in acute myeloid leukemia
Blood. 2018; 132(Suppl ):-Annual Meeting of the American Society of Hematology; December 1-4, 2018; San Diego.
Doi: 10.1182/blood-2018-99-110667
[Poster]
Web of Science
FullText
FullText_MUG
Panny, M; Prochazka, K; Neumeister, P; Nosslinger, T; Rathkolb, V; Holzer, K; Bohm, A; Keil, F
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R- the Austrian experience
ONCOL RES TREAT. 2018; 41: 46-46.
[Poster]
Web of Science
Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A
Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81.
[Poster]
Web of Science
Pansy,K; Fechter,K ; Greinix, H; Prochazka,K; Neumeister,P; Deutsch,A
Loss of Nr4a1 causes up-regulation of Nr4a3 and partially over-expression of p53 in Myc-driven lymphomagenesis
; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Poster]
Prochazka, K
CLL: State of the Art Therapy, First-line therapy
ONCOL RES TREAT. 2018; 41: 266-266.
Web of Science
Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P
Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50.
[Poster]
Web of Science
Unterluggauer, J; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J;
Molecular expression analysis reveals potential of translation initiation factors to serve as novel biomarkers for aggressive B-cell lymphomas.
Der Pathologe 39:67-68. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26, 2018; Berlin, GERMANY.
[Oral Communication]
FullText
Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164.
[Poster]
Web of Science
Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Rinner, B; Pichler, M; Weniger, M; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J
Specific translation initiation factors influence clinical course of aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2018; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Oral Communication]
Ehall, B; Pursche, B; Greinix, H; Prochazka, K; Sedej, M; Zoidl, M; Wroddnigg, T; Neumeister, P; Deutsch, A; Fechter, K;
Treatment of lymphoma cell lines with CXCR4 antagonists inhibits cell growth in vitro
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017.
[Poster]
Fechter, K;, Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017.
[Poster]
Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; SEP 29 - OCT 3, 2017 ; Stuttgart, GERMANY. 2017.
[Oral Communication]
Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108.
[Poster]
Web of Science
Panny, M; Prochazka, K; Holzer, K; Neumeister, P; Nosslinger, T; Rathkolb, V; Greinix, H; Keil, F
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis
ONCOL RES TREAT. 2017; 40: 69-70.
[Poster]
Web of Science
Pansy, K; Fechter, K; Greinix, H; Prochazka, K; Neumeister, P; Deutsch, A
Nr4a1 is implicated in gene regulation in a context specific manner in non-malignant lymphoid tissue
http://www.oegho.at/online-services/veranstaltungen/oegho-fruehjahrstagung-2017/fruehjahrstagung-2017.html. 2017; -OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA.
[Poster]
Uhl, B; Wenzl, K; Fechter, K; Prochazka, KT; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, A;
CCR7 expression is associated to favourable cancer specific survival of aggressive lymphoma patients.
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017.
[Poster]
Panny, M; Troppan, K; Neumeister, P; Nosslinger, T; Holzer, K; Greinix, H; Keil, F
TREATMENT OF HIGH RISK AGGRESSIVE B CELL LYMPHOMAS WITH DA EPOCH R- A RETROSPECTIVE ANALYSIS
HAEMATOLOGICA. 2016; 101: 698-698.-21st Congress of the European-Hematology-Association; JUN 09-12, 2016; Copenhagen, DENMARK.
[Poster]
Web of Science
Troppan, K; Beham, C; Greinix, H; Deutsch, A; Neumeister, P;
DOUBLE PROTEIN LYMPHOMA PATIENTS OF THE NON-GCB SUBTYPE HAVE AN INFERIOR PROGNOSIS WHEN TREATED WITH CHEMOIMMUNOTHERAPY.
HAEMATOLOGICA. HAEMATOLOGICA101: 396-397. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, JUN 09-12, 2016)
Web of Science
Troppan, K; Pregartner, G; Zach, V; Greinix, H; Neumeister, P
Identification of prognostic factors in patients with mature lymphoid malignancies undergoing autologous stem cell transplantation-a single center experience
BONE MARROW TRANSPL. 2016; 51: S506-S506.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
[Poster]
Web of Science
Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Beham-Schmid, C; Neumeister, P
NR4A1 AND NR4A3 POSSESS FUNCTIONAL REDUNDANCY BY REGULATING PRO-APOPTOTIC GENES IN AGGRESSIVE LYMPHOMAS.
HAEMATOLOGICA. 2015; 100: 544-544.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA.
[Poster]
Web of Science
Deutsch, AJA; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Greinix, HT; Beham-Schmid, C; Neumeister, P
NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
Lohberger, B; Rinner, B; Deutsch, A; Meditz, K; Troppan, K; Scheipl, S; Wibmer, C; Leithner, A; Liegl, B; Fröhlich, EV
Survivin Expression in 50 humanen Chordomproben – eine histologische und in vitro-Studie.
Jatros Orthopädie & Rheumatologie 2015
. 2015; 20(5):137-137.-32. Jahrestagung der Österreichischen Gesellschaft für Orthopädie und orthopädische Chirurgie; OCT 29-31, 2015; Vienna, AUSTRIA.
[Oral Communication]
Troopan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, G; Beham-Schmid, C; Neumeister, P; Deutsch, A
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients
ONCOL RES TREAT. 2015; 38: 63-64.
[Poster]
Web of Science
Troppan K, Wenzl K, Neumeister P, Beham-Schmid C, Przekopowitz M, Greinix H, H Schaider, Deutsch AJA
The chemokine receptor profile as distinctive criterion between normal B-cell subsets and as potential discriminative marker to identify the cell of origin in patients with chronic
lymphocytic leukemia and Richter syndrome
57th ASH Annual Meeting. 2015; -57th ASH Annual Meeting; DEC 5-8; Orlando, USA.
[Poster]
Troppan, K; Wenzl, K; Neumeister, P; Beham-Schmid, C; Przekopowitz, M; Greinix, HT; Schaider, H; Deutsch, AJA
The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
[Poster]
Web of Science
Wenzl K Pursche B Klescher D, Beham-Schmid C Deutsch AJA, Neumeister P, Troppan KT
Distinct chemokine receptor profiles in multiple myeloma cells compared to normal bone marrow cells
Memo magazine of european medical oncology Proceedings of the annual meeting of the Austrian society of haematology and medical oncology. 2015; -OEGHO; APR 23-25, 2015; Salzburg, Austria.
[Poster]
Wenzl, K; Troppan, K; Pursche, B; Bischof, M; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, AJA
Loss of NR4A1 Accelerates the Development of Aggressive Lymphomas in Myc Induced Cancerogenesis
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Beham-Schmid, C; Neumeister, P
NR4A3-MEDIATED APOPTOSIS SUPPRESSES LYMPHOMAGENESIS IN A XENOGRAFT MOUSE MODEL
HAEMATOLOGICA. .. 2014; 99: 136-136.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
Hoenigl, M; Duettmann, W; Huber-Krassnitzer, B; Wagner, J; Prattes, J; Troppan, K; Seeber, K; Raggam, RB; Wolfler, A; Krause, R
CORRELATION OF EARLY TROUGH LEVELS (DAY 4) WITH STEADY-STATE
POSACONAZOLE PLASMA CONCENTRATIONS - A COHORT STUDY.
. 2014; -24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); MAY 10-13, 2014; Barcelona, Spain.
[Poster]
Hoenigl, M; Duettmann, W; Seeber, K; Wolfler, A; Huber-Krassnitzer, B; Prattes, J; Troppan, K; Raggam, RB; Semmelrock, H; Prueller, F; Wagner, J; Krause, R
Posaconazole Plasma Concentrations: Correlation of Early Trough Levels (day 4) with Steady-State Concentrations.
. 2014; -6th Advances Against Aspergillosis; FEB 27 - MAR 1; Madrid, SPAIN.
[Poster]
Troppan, K; Wenzl, K; Deutsch, A; Pichler, M; Graupp, M; Beham-Schmid, C; Neumeister, P
HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA
HAEMATOLOGICA. 2014; 99: 135-135.
[Poster]
Web of Science
Troppan K; Wenzl K; Deutsch A; Schwarzenbacher D; Pichler M; Graupp M; Neumeister P
Hohe Expression von microRNA-199a_1 und microRNA-497_1 ist assoziiert mit besserem Überleben bei patienten mit aggressivem non-Hodgkin-Lymphom
Memo magazine of european medical oncology
Proceedings of the annual meeting of the Austrian society of haematology and medical oncology. 2014; 7(1):14-15.-Frühjahrstagung ÖGHO; APR 10-12, 2014; Innsbruck.
[Poster]
Troppan, KT; Wenzl, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells
ONCOL RES TREAT. 2014; 37: 72-73.
[Poster]
Web of Science
Wenzl, K; Troppan, K; Deutsch, A; Neumeister, P
ANALYSES OF NUCLEAR ORPHAN RECEPTOR EXPRESSION AND CYTOTOXICITY FOLLOWING ANTI-CD 20 MONOCLONAL ANTIBODY TREATMENT IN AGGRESSIVE NON-HODGKIN'S LYMPHOMAS
HAEMATOLOGICA. 2014; 99: 685-686.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
Wenzl, K; Troppan, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival
ONCOL RES TREAT. 2014; 37: 73-73.
[Poster]
Web of Science
Abdyli, L; Van de Caerin, C; Huber-Krassnitzer, B; Troppan, K; Theiler, G; Linkesch, W;
Multizentrische, einarmige Studie mit Pomalidomid in Kombination mit niedrig dosiertem Dexamethason bei Patienten mit refraktärem und/oder relapsiertem Multiplen Myelom.
Memo. 2013; 06(1/13):22-22.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz.
[Poster]
Duettmann, W; Koidl, C; Abdyli, L; Waitzl, B; Huber-Krassnitzer, B; Wagner, J; Schmidt, H; Troppan, K; Valentin, T; Wölfler, A; Krause, R; Hoenigl, M
Comparison of Galactomannan test from serum and urine specimens in patients with haematological malignancies: a cohort study
. 2013; -23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); APR 27-30, 2013; Berlin, GERMANY.
[Oral Communication]
Hoenigl, M; Duettmann, W; Koidl, C; Buzina, W; Troppan, K; Wölfler, A; Fruhwald, S; Wagner, J; Seeber, K; Valentin T; Zollner-Schwetz, I; Thornton, C; Krause, R
Bronchoalveolar lavage lateral-flow device test for diagnosing invasive pulmonary aspergillosis.
. 2013; -7. Österreichischer Infektionskongress; APR 10-13, 2013; Saalfelden, AUSTRIA.
[Poster]
Hoenigl, M; Duettmann, W; Koidl, C; Waitzl, B; Seeber, K; Wagner, J; Troppan, K; Raggam, RB; Krause, R; Thornton, C
Bronchoalveolar lavage lateral-flow device test for diagnosing invasive pulmonary aspergillosis.
. 2013; -International Meeting on Emerging Diseases and Surveillance (IMED); FEB 15-18, 2013; Vienna, AUSTRIA.
[Poster]
Huber-Krassnitzer, B; Troppan, K; Abdyli, L; Theiler, G; Van de Caerin, C; Linkesch, W;
Randomisierte, doppelt-verblindete Parallelstudie zum Vergleich von Fidaxomicin mit Vancomycin bei Patienten mit Clostridium difficile Infektion unter immunsuppressiver Therapie.
Memo . 2013; 06(1/13):23-23.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz.
[Poster]
Theiler, G; Troppan, K; Abdyli, L; Huber-Krassnitzer, B; Van de Caerin, C; Linkesch, W;
Ibrutinib versus Ofatumumab bei Patienten mit relapsierter oder refraktärer chronischer lymphatischer Leukämie/small lymphocytic lymphoma (Phase-III-Studie).
Memo. 2013; 06(1/13):22-22.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz.
[Poster]
Troppan, K; Abdyli, L; Huber-Krassnitzer, B; Van de Caerin, C; Theiler, G; Linkesch, W;
Randomisierte, doppelblinde Phase-III-Studie, die orales MLN9708 plus Lenalidomid/Dexamethason versus Placebo plus Lenalidomid/Dexamethason bei erwachsenen Patienten mit relapsiertem/refraktärem Multiplen Myelom vergleicht.
Memo. 2013; 06(1/13):21-21.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz.
[Poster]
Troppan, K; Valentin, A; Linkesch, W
90-Yttrium-Ibritumomab-Tiuxetan as First-Line Therapy or as Consolidation Treatment in advanced stage Follicukar NHL: Longterm results after a median follow-up of 61 months
BLOOD. 2013; 122(21):5123--55th Annual Meeting of the American Society of Hematology; Dez 7-10, 2013; New Orleans, USA.
Troppan, K; Van de Caerin, C; Theiler, G; Abdyli, L; Huber-Krassnitzer, B; Linkesch, W;
Eine randomisierte, zweiarmige Phase-III-Studie, die Alisertib versus Pralatrexat/Gemcitabine bei Patienten mit relapsierten oder refraktären peripheren T-Zell Lymphomen vergleicht.
Memo. 2013; 06(1/13):20-20.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz.
[Poster]
Van de Caerin, C; Huber-Krassnitzer, B; Theiler, G; Abdyli, L; Troppan, K; Linkesch, W;
Randomisierte, doppelblinde, multizentrische Studie, die Densoumab versus Zoledronsäure (Zometa) bei Patienten mit neu diagnostiziertem Multiplem Myelom und Knochenbeteiligung vergleicht.
Memo. 2013; 06(1/13):21-21.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz.
[Poster]
Van de Caerin, C; Theiler, G; Huber-Krassnitzer, B; Troppan, K; Abdyli, L; Linkesch, W;
Phase-II-Studie, die den Effekt von Spiegelmer NOX-H94 auf chronische Anämie bei Patienten mit Multiplem Myelom oder Lymphom untersuchen soll.
Memo. 2013; 06(1/13):20-20.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz.
[Poster]
Wagner J, Schilcher G, Zollner-Schwetz I, Hoenigl M, Valentin T, Ribitsch W, Horina J, Rosenkranz AR, Grisold A, Unteregger M, Troppan K, Valentin A, Neumeister P, Krause R
MICROBIOLOGICAL SCREENING FOR DETECTION OF CENTRAL VENOUS CATHETER RELATED BLOODSTREAM INFECTIONS
The Journal of Vascular Access. 2013; 14(1):-8th International Congress on Vascular Access; April 25-27; Prague, Czech Republic.
[Poster]
Wagner J, Schilcher G, Zollner-Schwetz I, Hönigl M, Valentin T, Ribitsch W, Horina J, Rosenkranz AR, Grisold A, Unteregger M, Troppan K, Valentin A, Neumeister P, Krause R
Microbiological screening for detection of central venous catheter related bloodstream infections
7. Infektionskongress. 2013; -7. Infektionskongress; APR 10-13; Saalfelden, AUSTRIA.
[Poster]
Wenzl, K; Troppan, K; Deutsch, AJA, Linkesch, W; Neumeister, P, Beham-Schmid, C
Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas
Proceedings of 55th ASH Annual Meeting. 2013; -55th ASH Annual Meeting; December 7-10, 2013 ; New Orleans.
FullText
Wenzl, K; Troppan, K; Deutsch, AJA; Linkesch, W; Neumeister, P; Beham-Schmid, C;
Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas.
BLOOD. BLOOD122: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013)
Doi: 10.1182/blood.V122.21.4852.4852
Web of Science
FullText
FullText_MUG
Wenzl,K;Troppan,K;Deutsch,A;Linkesch,W;Neumeister,P;Beham-schmid,Ch
Distinct Chemokine Receptor Profile in Chronic Lymphocyte Leukemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared to Germinal Center B Cells and de novo Diffuse Large B Cell Lymphomas
BLOOD. 2013; 122(21):4852--55th Annual Meeting of the American Society of Hematology; Dez 7-10, 2013; New Orleans, USA.
Zinke-Cerwenka, W; Troppan, K; Beham-Schmid, C; Pucher, F; Linkesch, W; Neumeister, P
Brentuximab Vedotin is an effective Treatment of Classical Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
Haematologica. 2013; 98(1):572-572.-18th Congress of the European Hematology Association; JUN 13-16, 2013; Stockholm, SWEDEN.
[Poster]
Deutsch, A; Pichler, M; Reitter, S; Troppan, K; Beham-SChmid, C; Neumeister, P.
Reduced NR4A1 expression is associated with poor survival in patients with aggressive lymphomas.
2012 Proceedings of the annual meeting of the Austrian Society of Haematology and Oncology. 2012; 5(1):5-5.-Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria.
[Poster]
Deutsch, AJA; Pichler, M; Reitter, S; Troppan, K; Beham-Schmid, C; Neumeister, P;
Reduction of NR4A1 is associated with poor survival aggressive lymphomas.
ONKOLOGIE. 2012; 35: 104-104.-Gemeinsame Jahrestagung 2012 der DGHO, ÖGHO, SGMO und SGH+SSH ; Okt 19-23, 2012; Stuttgart.
[Oral Communication]
Web of Science
Sill, H; Troppan, K
Acute myeloid leukemia
ÖGHO Juniorakademie; SEP 14-15, 2012; Fuschl, Austria. 2012.
[Oral Communication]
Troppan, K;
Fallpräsentation
ÖGHO Juniorakademie
ÖGHO Juniorakademie; SEP 14-15, 2012; Fuschl, Austria. 2012.
[Oral Communication]
Troppan, K; Van de Caerin, C; Unteregger, M; Linkesch, W
A randomized, controlled, double-blind phase III trial to compare the efficacy, safety and pharmacokinetics of GP2013 plus CVP vs. MabThera plus CVP, followed by GP2013 or MabThera maintenance therapy in patients with previously untreated, advanced stage follicular lympoma.
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Troppan, K; Van de Caerin, C; Unteregger, M; Linkesch, W
A phase IIIb, single-arm study of Mabthera SC (subcutaneous rituximab) induction + maintenance therapy in patients with relapsed, indolent non-Hodgkin's lymphoma
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Unteregger, M; Troppan, K; Van der Caerin, C; Linkesch, W
An open label, multicenter study investigating the saftety and efficacy of ofatumumab therapy versus physician`s choice in patients with bulky fludarabin refractory chronic lymphocytic leukemia (CLL).
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Unteregger, M; Troppan, K; Van der Caerin, C; Linkesch, W
Ofatumumab versus rituximab salvage chemoimmunotherapy followed by ASCT in relapsed or refractory DLBCL
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Valentin, A; Unteregger, M; Troppan, K; Zinke-Cerwenka, W; Cerroni, L; Linkesch, W; Neumeister, P;
Unrelated stem cell transplantation induces long term disease control in patients with blastic plasmocytoid dendritic cell neoplasm.
ONKOLOGIE. 2012; 35: 212-213.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart.
[Poster]
Web of Science
Valentin, A; Unteregger, MJ; Troppan, K; Zinke-Cerwenka, W; Cerroni, L; Linkesch, W; Neumeister, P
Krankheitsfreies Langzeitüberleben durch allogene Fremdspenderstammzelltransplantation bei Patienten mit Blastisch Plasmozytoid Dendritischer Zellneoplasie
Onkologie. 2012; 6/2012: 11-11.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart.
[Poster]
Van de Caerin, C; Unteregger, M; Troppan, K; Linkesch, W
An open-label, multicenter, expanded access study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF).
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Stelzl, E; Troppan, KT; Winkler, M; Kessler, HH
Early detection of HIV-1 drug mutations in clinical samples with low viral load may be possible with a new open channel mode protocol on the new Siemens sample preparation module
Clinical Chemistry and Laboratory Medicine. 2010; 48(5):A4-A5.-ISMD2010 - 8th International Symposium on Molecular Diagnostics; JUN 3-5, 2010; Graz, Austria.
[Oral Communication]